Consultant Psychiatrist and College Tutor Parkwood, East Park Drive Blackpool, FY3 8PW, Lancashire, United Kingdom.
Indian J Psychiatry. 2010 Jul;52(3):267-9. doi: 10.4103/0019-5545.70989.
Patients with borderline personality disorder (BPD) show significant impairment in the domain of interpersonal and social functioning and may use the resources of health and social services extensively, with little beneficial outcome. At present there are no clear guidelines in literature for the use of pharmacotherapy in the management of BPD. According to the scanty literature available in the form of case reports and small studies, clozapine has been demonstrated to be effective in the management of BPD. The case presented here describes the effectiveness of clozapine in a young female patient with severe BPD (without psychotic features), who had repeated and prolonged periods of hospitalization and was successfully treated with a moderate dose of clozapine, following a failure to improve with other psychotropic medications. More studies are suggested to evaluate the efficacy of clozapine in patients with BPD, both with and without psychotic features, to find out the optimum dose and to weigh the risk and benefits of clozapine.
边缘型人格障碍(BPD)患者在人际关系和社交功能领域存在明显障碍,可能会广泛利用卫生和社会服务资源,但收效甚微。目前,文献中尚无关于BPD 药物治疗管理的明确指南。根据现有的病例报告和小型研究文献,氯氮平已被证明在 BPD 的治疗中有效。本文介绍了一例严重 BPD(无精神病特征)的年轻女性患者使用氯氮平的疗效,该患者反复发作且持续时间长,在其他精神药物治疗无效后,使用中等剂量氯氮平成功治疗。建议进行更多研究,以评估氯氮平对有和无精神病特征的 BPD 患者的疗效,确定最佳剂量,并权衡氯氮平的风险和获益。